Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

206 trials with published results (7%)

Research Maturity

1857 completed trials (61% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.8%

84 terminated out of 3035 trials

Success Rate

95.7%

+9.1% vs benchmark

Late-Stage Pipeline

10%

298 trials in Phase 3/4

Results Transparency

11%

206 of 1857 completed with results

Key Signals

206 with results96% success84 terminated

Data Visualizations

Phase Distribution

1,658Total
Not Applicable (1140)
Early P 1 (12)
P 1 (82)
P 2 (126)
P 3 (182)
P 4 (116)

Trial Status

Completed1,857
Recruiting375
Unknown369
Active Not Recruiting156
Not Yet Recruiting93
Terminated84

Trial Success Rate

95.7%

Benchmark: 86.5%

Based on 1857 completed trials

Clinical Trials (3035)

Showing 20 of 20 trials
NCT07613099Phase 3Recruiting

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

NCT04053088Active Not RecruitingPrimary

SAVR: IMPACT of Pre-existing Comorbidities on Patient Outcomes and Prosthetic Valve Performance in a Real-world Setting.

NCT02439775Not ApplicableCompleted

SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System

NCT05198674Not ApplicableActive Not Recruiting

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

NCT04241328RecruitingPrimary

Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery

NCT04617834Active Not RecruitingPrimary

Enhancing Rural Health Via Cardiovascular Telehealth for Rural Patients Implementation (E-VICTORS)

NCT05882045Phase 3Completed

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

NCT07256249RecruitingPrimary

Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry

NCT07187596Active Not Recruiting

Mortality Outcome of Controlled Hypertension

NCT03736226Active Not RecruitingPrimary

A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China

NCT06043310Active Not Recruiting

Estrogen and Microvascular Function

NCT07613294Phase 3Recruiting

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

NCT07617844RecruitingPrimary

Multimodal mAgnetic Resonance imaGIng in Cardiovascular Disease

NCT04055428Phase 2Recruiting

NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals

NCT07482943Phase 4Recruiting

The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure

NCT07727135Not ApplicableNot Yet Recruiting

Rapid or Ultra-rapid Diagnosis of Myocardial Infarction Using High-Sensitivity Cardiac Troponin on Hospital Presentation

NCT04877197Not ApplicableRecruiting

Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care

NCT07064473Phase 3Recruiting

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT07717723Not ApplicableRecruiting

Supporting Mental Health and Reducing Care Stress in Caregivers of Persons With Cardiovascular Disease

NCT07258290Not ApplicableRecruiting

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

Scroll to load more

Research Network

Activity Timeline